HeartSciences Inc. (HSCS) — Financial statements
Income statement, balance sheet, and cash flow for HeartSciences Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00↓76.6% | 0.02↑261.2% | 0.01↓64.2% | 0.01↓43.9% | 0.03 | |
| Cost of Revenue | 0.13↑28.3% | 0.10↑240.7% | 0.03↓13.8% | 0.03↓22.2% | 0.04 | |
| Gross Profit | -0.13↓51.9% | -0.08↓236.4% | -0.02↓22.3% | -0.02↓7.6% | -0.02 | |
| Operating Expenses | ||||||
| R&D Expenses | 4↑52.4% | 3↑17.0% | 2↓18.0% | 3↑75.7% | 2 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 4↑14.8% | 3↓7.8% | 4↑114.9% | 2↑100.7% | 0.84 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 8↑32.2% | 6↑2.2% | 6↑29.8% | 5↑83.9% | 3 | |
| Total Costs & Expenses | 8↑32.1% | 6↑3.4% | 6↑29.5% | 5↑82.1% | 3 | |
| Operating Results | ||||||
| Operating Income | -8↓32.5% | -6↓3.2% | -6↓29.8% | -5↓83.4% | -3 | |
| Depreciation & Amortization | 0.13↑34.5% | 0.10↑253.5% | 0.03↑1.3% | 0.03↓21.0% | 0.03 | |
| EBITDA | -8↓32.2% | -6↓1.2% | -6↓37.3% | -4↓93.8% | -2 | |
| EBIT | -8↓32.2% | -6↓2.3% | -6↓37.1% | -4↓92.1% | -2 | |
| Interest & Other Income | ||||||
| Net Interest Income | -0.50↓41.3% | -0.35↓45.6% | -0.24↑34.6% | -0.37↓180.6% | -0.13 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.50↑41.3% | 0.35↑45.6% | 0.24↓34.6% | 0.37↑180.6% | 0.13 | |
| Non-Operating Income | -0.09↓60.7% | -0.05↓2856.8% | -0.00↑99.3% | -0.25↓1.7% | -0.25 | |
| Other Income / Expenses | -0.41↓37.8% | -0.30↓24.1% | -0.24↓103.0% | -0.12↓202.5% | 0.12 | |
| Income Before Tax | -9↓32.7% | -7↓3.9% | -6↓31.6% | -5↓96.9% | -2 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -9↓32.7% | -7↓3.9% | -6↓31.6% | -5↓96.9% | -2 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -9↓32.7% | -7↓3.9% | -6↓31.6% | -5↓96.9% | -2 | |
| Bottom-Line Net Income | -9↓32.7% | -7↓3.9% | -6↓31.6% | -5↓96.9% | -2 | |
| EPS (Basic) | -9.34↑50.2% | -18.74↑99.7% | -6,173.88↓4375.8% | -137.94↓77.1% | -77.89 | |
| EPS (Diluted) | -9.34↑50.2% | -18.74↑99.7% | -6,173.88↓4375.8% | -137.94↓77.1% | -77.89 | |
| Weighted Average Shares | 0.94↑166.2% | 0.35↑343.4% | 0.08↑139.6% | 0.03↑0.2% | 0.03 | |
| Weighted Average Diluted Shares | 0.94↑166.2% | 0.35↑343.4% | 0.08↑139.6% | 0.03↑0.2% | 0.03 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.